Skip to main content
. 2022 May;11(5):738–747. doi: 10.21037/tp-22-139

Table 2. Analysis of glucocorticoid use and condition on admission in SMPP.

Condition on admission Glucocorticoid use (N=31) Normal treatment (N=28) t/χ2 P value
Fever before admission (days) 7.09±5.70 4.39±3.34 2.191 0.033
Cough before admission (days) 9.96±7.56 7.17±5.54 1.16 0.251
Maximum temperature before admission 39.32±0.88 39.40±1.29 −0.26 0.796
WBC after admission (109/L) 10.34±5.42 9.67±3.76 0.539 0.592
CRP after admission (mg/L) 21.20±19.39 16.63±11.17 0.795 0.43
PLT after admission (109/L) 355.03±144.39 309.85±173.01 1.093 0.279
MP titer after admission (1:X) 370.32±258.19 253.24±159.14 1.784 0.081

SMPP, severe Mycoplasma pneumoniae pneumonia; MP, Mycoplasma pneumoniae; WBC, white blood cell; CRP, C-reactive protein; PLT, platelet.